A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate
Clinical trial NCT05469854 · RECRUITING
Trial details
- NCT number
- NCT05469854
- Sponsor
- Cinclus Pharma Holding AB
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-13
- Primary completion
- 2026-11-30
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.